Cytori says new Japanese regen laws should goose Celution sales

Cytori Therapuetics says that two new laws passed in Japan pertaining to regenerative medicine should make it easier for the company to commercialize its Cytori Cell Therapy and Celution Systems . As management perceives it, Cytori will be able to provide the Celution System and autologous adipose-derived regenerative cells under the lowest risk category for many procedures which requires less-stringent regulatory approval and oversight processes.

http://ift.tt/1yjWtPW